Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Fiorentino, Maria ^a   Levine, Myron M ^b   Sztein, Marcelo B ^b   Fasano, Alessio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; SHIGELLA VACCINE;

ANTIGEN FUNCTION; ANTIGEN TRAFFICKING; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INTESTINE CELL; NONHUMAN; PERMEABILITY BARRIER; SHIGELLA; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLOSIS; SMALL INTESTINE; TIGHT JUNCTION; WILD TYPE;

CACO-2 CELLS; CELL SURVIVAL; COLONY COUNT, MICROBIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-8; INTESTINES; MODELS, BIOLOGICAL; PERMEABILITY; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA VACCINES; TIGHT JUNCTIONS; VACCINES, ATTENUATED;

EID: 84897397249     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085211     Document Type: Article

References (63)

1. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, et al. (1999) Globalburden of Shigella infections: implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization 77: 651-666. (Pubitemid 29446617)
2. Gupta A, Polyak CS, Bishop RD, Sobel J, Mintz ED (2004) Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38: 1372-1377.
3. Black RE, Brown KH, Becker S (1984) Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh. Pediatrics 73: 799-805. (Pubitemid 14111780)
4. Levine MM, DuPont HL, Formal SB, Hornick RB, Takeuchi A, et al. (1973) Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. The Journal of infectious diseases 127: 261-270.
5. Fasano A, Noriega FR, Maneval DR, Jr., Chanasongcram S, Russell R, et al. (1995) Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. The Journal of clinical investigation 95: 2853-2861.
6. Yavzori M, Cohen D, Orr N (2002) Prevalence of the genes for shigella enterotoxins 1 and 2 among clinical isolates of shigella in Israel. Epidemiology and infection 128: 533-535. (Pubitemid 34716384)
7. Niyogi SK, Vargas M, Vila J (2004) Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 10: 574-576.
8. Noriega FR, Liao FM, Formal SB, Fasano A, Levine MM (1995) Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. The Journal of infectious diseases 172: 1408-1410.
9. Nataro JP, Seriwatana J, Fasano A, Maneval DR, Guers LD, et al. (1995) Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infection and immunity 63: 4721-4728.
10. Vargas M, Gascon J, Jimenez De Anta MT, Vila J (1999) Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. Journal of clinical microbiology 37: 3608-3611. (Pubitemid 29491101)
11. DuPont HL, Levine MM, Hornick RB, Formal SB (1989) Inoculum size in shigellosis and implications for expected mode of transmission. The Journal of infectious diseases 159: 1126-1128. (Pubitemid 19138818)
12. Shipley ST, Panda A, Khan AQ, Kriel EH, Maciel M, Jr., et al. (2010) A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis). Comparative medicine 60: 54-61.
13. Shim DH, Suzuki T, Chang SY, Park SM, Sansonetti PJ, et al. (2007) New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies. Journal of immunology (Baltimore, Md: 1950) 178: 2476-2482.
14. Zhang Z, Jin L, Champion G, Seydel KB, Stanley SL, Jr. (2001) Shigella infection in a SCID mouse-human intestinal xenograft model: role for neutrophils in containing bacterial dissemination in human intestine. Infection and immunity 69: 3240-3247. (Pubitemid 32332222)
15. Perdomo OJ, Cavaillon JM, Huerre M, Ohayon H, Gounon P, et al. (1994) Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. The Journal of experimental medicine 180: 1307-1319. (Pubitemid 24289604)
16. Rout WR, Formal SB, Giannella RA, Dammin GJ (1975) Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology 68: 270-278.
17. Jeong KI, Zhang Q, Nunnari J, Tzipori S (2010) A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1. The Journal of infectious diseases 201: 903-911.
18. Dinari G, Hale TL, Austin SW, Formal SB (1987) Local and systemic antibody responses to Shigella infection in rhesus monkeys. The Journal of infectious diseases 155: 1065-1069. (Pubitemid 17062854)
19. Katakura S, Reinholt FP, Karnell A, Huan PT, Trach DD, et al. (1990) The pathology of Shigella flexneri infection in rhesus monkeys: an endoscopic and histopathological study of colonic lesions. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 98: 313-319. (Pubitemid 20177181)
20. Oaks EV, Hale TL, Formal SB (1986) Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infection and immunity 53: 57-63. (Pubitemid 16084364)
21. Porter CK, Thura N, Ranallo RT, Riddle MS (2012) The Shigella human challenge model. Epidemiology and infection: 1-10.
22. Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB (2007) Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nature reviews Microbiology 5: 540-553. (Pubitemid 46925382)
23. Kotloff KL, Losonsky GA, Nataro JP, Wasserman SS, Hale TL, et al. (1995) Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2. Vaccine 13: 495-502.
24. Kotloff KL, Nataro JP, Losonsky GA, Wasserman SS, Hale TL, et al. (1995) A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine 13: 1488-1494.
25. Cohen D, Green MS, Block C, Slepon R, Ofek I (1991) Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. Journal of clinical microbiology 29: 386-389.
26. DuPont HL, Hornick RB, Snyder MJ, Libonati JP, Formal SB, et al. (1972) Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. The Journal of infectious diseases 125: 12-16.
27. Coron E, Flamant M, Aubert P, Wedel T, Pedron T, et al. (2009) Characterisation of early mucosal and neuronal lesions following Shigella flexneri infection in human colon. PloS one 4: e4713.
28. Flamant M, Aubert P, Rolli-Derkinderen M, Bourreille A, Neunlist MR, et al. (2011) Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione. Gut 60: 473-484.
29. Sakaguchi T, Kohler H, Gu X, McCormick BA, Reinecker HC (2002) Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cellular microbiology 4: 367-381. (Pubitemid 34727540)
30. Wu T, Grassel C, Levine MM, Barry EM (2011) Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit. Infection and immunity 79: 4912-4922.
31. Mounier J, Vasselon T, Hellio R, Lesourd M, Sansonetti PJ (1992) Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole. Infection and immunity 60: 237-248.
32. Vasselon T, Mounier J, Hellio R, Sansonetti PJ (1992) Movement along actin filaments of the perijunctional area and de novo polymerization of cellular actin are required for Shigella flexneri colonization of epithelial Caco-2 cell monolayers. Infection and immunity 60: 1031-1040.
33. Lindberg AA, Karnell A, Stocker BA, Katakura S, Sweiha H, et al. (1988) Development of an auxotrophic oral live Shigella flexneri vaccine. Vaccine 6: 146-150. (Pubitemid 18089139)
34. Lindberg AA, Karnell A, Pal T, Sweiha H, Hultenby K, et al. (1990) Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine. Microbial pathogenesis 8: 433-440. (Pubitemid 20341496)
35. Cersini A, Salvia AM, Bernardini ML (1998) Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. Infection and immunity 66: 549-557. (Pubitemid 28074194)
36. Formal SB, Dammin GJ, Labrec EH, Schneider H (1958) Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs. Journal of Bacteriology 75: 604-610.
37. Venkatesan MM, Hartman AB, Newland JW, Ivanova VS, Hale TL, et al. (2002) Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine. Infection and immunity 70: 2950-2958. (Pubitemid 34564153)
38. Kotloff KL, Pasetti MF, Barry EM, Nataro JP, Wasserman SS, et al. (2004) Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. The Journal of infectious diseases 190: 1745-1754. (Pubitemid 39487817)
39. Kotloff KL, Simon JK, Pasetti MF, Sztein MB, Wooden SL, et al. (2007) Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media. Human vaccines 3: 268-275.
40. Fiorentino M, Lammers KM, Levine MM, Sztein MB, Fasano A (2013) In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines. Frontiers in immunology 4: 17.
41. Rao R (2009) Occludin phosphorylation in regulation of epithelial tight junctions. Annals of the New York Academy of Sciences 1165: 62-68.
42. Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, et al. (1996) Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. The Journal of cell biology 134: 1031-1049. (Pubitemid 26278226)
43. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, et al. (1996) Occludin is a functional component of the tight junction. Journal of cell science 109 (Pt 9): 2287-2298. (Pubitemid 26325491)
44. Seth A, Sheth P, Elias BC, Rao R (2007) Protein phosphatases 2A and 1 interact with occludin and negatively regulate the assembly of tight junctions in the CACO-2 cell monolayer. The Journal of biological chemistry 282: 11487-11498. (Pubitemid 47100808)
45. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S (1997) Possible involvement of phosphorylation of occludin in tight junction formation. The Journal of cell biology 137: 1393-1401. (Pubitemid 27265950)
46. Wong V (1997) Phosphorylation of occludin correlates with occludin localization and function at the tight junction. The American Journal of Physiology 273: C1859-1867.
47. Taylor DN, Echeverria P (1986) Etiology and epidemiology of travelers' diarrhea in Asia. Reviews of infectious diseases 8 Suppl 2: S136-141.
48. Taylor DN, Houston R, Shlim DR, Bhaibulaya M, Ungar BL, et al. (1988) Etiology of diarrhea among travelers and foreign residents in Nepal. JAMA : the journal of the American Medical Association 260: 1245-1248.
49. Pignata S, Maggini L, Zarrilli R, Rea A, Acquaviva AM (1994) The enterocyte-like differentiation of the Caco-2 tumor cell line strongly correlates with responsiveness to cAMP and activation of kinase A pathway. Cell growth &differentiation : the molecular biology journal of the American Association for Cancer Research 5: 967-973.
50. Hidalgo IJ, Raub TJ, Borchardt RT (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96: 736-749. (Pubitemid 19057595)
51. Artursson P (1990) Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. Journal of pharmaceutical sciences 79: 476-482.
52. Dorfel MJ, Huber O (2012) Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. Journal of biomedicine &biotechnology 2012: 807356.
53. Suzuki T, Elias BC, Seth A, Shen L, Turner JR, et al. (2009) PKC eta regulates occludin phosphorylation and epithelial tight junction integrity. Proceedings of the National Academy of Sciences of the United States of America 106: 61-66.
54. Sundstrom JM, Tash BR, Murakami T, Flanagan JM, Bewley MC, et al. (2009) Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach. Journal of proteome research 8: 808-817.
55. Murakami T, Felinski EA, Antonetti DA (2009) Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. The Journal of biological chemistry 284: 21036-21046.
56. Dorfel MJ, Westphal JK, Bellmann C, Krug SM, Cording J, et al. (2013) CK2-dependent phosphorylation of occludin regulates the interaction with ZO-proteins and tight junction integrity. Cell communication and signaling : CCS 11: 40-811X-811-840.
57. Raleigh DR, Boe DM, Yu D, Weber CR, Marchiando AM, et al. (2011) Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. The Journal of cell biology 193: 565-582.
58. Farfan MJ, Toro CS, Barry EM, Nataro JP (2011) Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells. FEMS immunology and medical microbiology 61: 332-339.
59. Zurawski DV, Mumy KL, Faherty CS, McCormick BA, Maurelli AT (2009) Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Molecular microbiology 71: 350-368.
60. Nandakumar NS, Pugazhendhi S, Ramakrishna BS (2009) Effects of enteropathogenic bacteria & lactobacilli on chemokine secretion & Toll like receptor gene expression in two human colonic epithelial cell lines. The Indian journal of medical research 130: 170-178.
61. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, et al. (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. The Journal of clinical investigation 95: 55-65.
62. Fasano A, Noriega FR, Liao FM, Wang W, Levine MM (1997) Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut 40: 505-511. (Pubitemid 27204931)
63. Faherty CS, Harper JM, Shea-Donohue T, Barry EM, Kaper JB, et al. (2012) Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo. PloS one 7: e49980.